VFA
BOLD

Virtus Fund Advisers’s Audentes Therapeutics, Inc BOLD Stock Holding History

Virtus Fund Advisers’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$372K Buy
+11,898
New +$327K ﹤0.01% 379

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Virtus Fund Advisers's BOLD Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Audentes Therapeutics, Inc (BOLD) in Q4 2017: 11,898 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #379 among its holdings.

89 funds tracked by Wall St. Rank hold BOLD as of Q4 2017.

  • Virtus Fund Advisers held 11,898 shares of Audentes Therapeutics, Inc worth $372K as of Q4 2017.
  • Audentes Therapeutics, Inc was a new Virtus Fund Advisers position in Q4 2017.
  • Audentes Therapeutics, Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #379 holding.
  • 89 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.